Europe Conjugate Vaccine market Witnessing Robust Growth and Growing at the CAGR of 3.6% during forecast period
Europe Conjugate Vaccine Market: Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases.
(EMAILWIRE.COM, February 14, 2019 ) Europe Conjugate Vaccine Market: Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. Europe is a market with stable growth for conjugate vaccines. The conjugate vaccine market in Europe is expected to expand at a CAGR of 3.6% leading to a revenue of USD 8.94 Bn by 2023. By volume, it is anticipated to reach 504.46 Million units by 2023, expanding at a CAGR of 3.7%.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/europe-conjugate-vaccine-market/11303/#requestforsample
The U.K. was the first country to introduce MenB-4C into their National Infant Immunization Program (2015). In all EU/EEA countries, Hib vaccination has been part of the immunization programs, since 2010, and high coverage has been sustained.
Market Segmentation:
o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into pediatric and adult.
o Based on countries, the Europe market is divided into EU5 and Rest of EU.
Key growth factors:
The European market will not display any extraordinary growth but average figures. Key growth factors include increasing emphasis on and availability of funds for research and development. Moreover, advancements in medical science, awareness about the availability of a higher number of vaccines for diseases will drive the growth of this market. Increasing vaccination programs by government, their initiatives, and increase in research and development activities will result in the growth of this market.
Threats and key players:
o The Europe conjugate vaccine market is expected to grow at a steady pace. The scope for significant growth is limited. Vaccine shortages are a major problem which will hinder the growth of the market. The shortage of vaccines affecting some EU/EEA Member States had direct effects on the delivery of national vaccination programmes. Since 2015, nine EU/EEA member states had to adjust their immunization policies.
o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
Get Discount & Customization of this Report Here:https://www.researchreporthub.com/report/europe-conjugate-vaccine-market/11303/
Table Of Content
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary - II
Chapter 2: Market overview
2.1. Market definitions
2.2. Europe market overview by revenue
- Europe historical (2015-2017) market revenue (USD Bn)
- Europe forecasted (2018-2023) market revenue (USD Bn)
- Country-wise market (2018-2023) revenue (USD Bn)
2.3. Europe market overview by volume
- Europe historical (2015-2017) market volume (Million units)
- Europe forecasted (2018-2023) market volume (Million units)
- Country-wise (2018-2023) market volume (Million units)
2.4. Europe market drivers and challenges
2.4.1. Europe market drivers
2.4.2. Europe market challenges
2.5. Europe market trends
2.6. Value chain
2.7.1. Country-specific market overview EU5
- Observation
- Key competitors
2.7.1(A) Country-specific market overview EU5 - by revenue and by volume
- EU5 historical (2015-2017) market revenue (USD Bn)
- EU5 forecasted (2018-2023) market revenue (USD Bn)
- EU5 historical (2015-2017) market volume (Million units)
- EU5 forecasted (2018-2023) market volume (Million units)
2.7.2. Country-specific market overview Rest of EU
- Observation
- Key competitors
2.7.2(A) Country-specific market overview Rest of EU by revenue and by volume
- Rest of EU historical (2015-2017) market revenue (USD Bn)
- Rest of EU forecasted (2018-2023) market revenue (USD Bn)
- Rest of EU historical (2015-2017) market volume (Million units)
- Rest of EU forecasted (2018-2023) market volume (Million units)
Chapter 3: Europe major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal Europe (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib Europe (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP Europe (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal Europe (USD Bn, Million units)
.....
Get Complete TOC with Figures and Tables Here:https://www.researchreporthub.com/report/europe-conjugate-vaccine-market/11303/#toc
Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
About US
Research Report Hub
Sector 04, Plot 101, Sant Nagar,
Moshi PCNDTA, Pune, 412105
Maharashtra, India
Web:www.researchreporthub.com
Find us on: <||>rnhttps://www.facebook.com/reasearchreporthub/ <||>rnhttps://twitter.com/hub_report <||>rnhttps://www.linkedin.com/company/research-report-hub/
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/europe-conjugate-vaccine-market/11303/#requestforsample
The U.K. was the first country to introduce MenB-4C into their National Infant Immunization Program (2015). In all EU/EEA countries, Hib vaccination has been part of the immunization programs, since 2010, and high coverage has been sustained.
Market Segmentation:
o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into pediatric and adult.
o Based on countries, the Europe market is divided into EU5 and Rest of EU.
Key growth factors:
The European market will not display any extraordinary growth but average figures. Key growth factors include increasing emphasis on and availability of funds for research and development. Moreover, advancements in medical science, awareness about the availability of a higher number of vaccines for diseases will drive the growth of this market. Increasing vaccination programs by government, their initiatives, and increase in research and development activities will result in the growth of this market.
Threats and key players:
o The Europe conjugate vaccine market is expected to grow at a steady pace. The scope for significant growth is limited. Vaccine shortages are a major problem which will hinder the growth of the market. The shortage of vaccines affecting some EU/EEA Member States had direct effects on the delivery of national vaccination programmes. Since 2015, nine EU/EEA member states had to adjust their immunization policies.
o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
Get Discount & Customization of this Report Here:https://www.researchreporthub.com/report/europe-conjugate-vaccine-market/11303/
Table Of Content
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary - II
Chapter 2: Market overview
2.1. Market definitions
2.2. Europe market overview by revenue
- Europe historical (2015-2017) market revenue (USD Bn)
- Europe forecasted (2018-2023) market revenue (USD Bn)
- Country-wise market (2018-2023) revenue (USD Bn)
2.3. Europe market overview by volume
- Europe historical (2015-2017) market volume (Million units)
- Europe forecasted (2018-2023) market volume (Million units)
- Country-wise (2018-2023) market volume (Million units)
2.4. Europe market drivers and challenges
2.4.1. Europe market drivers
2.4.2. Europe market challenges
2.5. Europe market trends
2.6. Value chain
2.7.1. Country-specific market overview EU5
- Observation
- Key competitors
2.7.1(A) Country-specific market overview EU5 - by revenue and by volume
- EU5 historical (2015-2017) market revenue (USD Bn)
- EU5 forecasted (2018-2023) market revenue (USD Bn)
- EU5 historical (2015-2017) market volume (Million units)
- EU5 forecasted (2018-2023) market volume (Million units)
2.7.2. Country-specific market overview Rest of EU
- Observation
- Key competitors
2.7.2(A) Country-specific market overview Rest of EU by revenue and by volume
- Rest of EU historical (2015-2017) market revenue (USD Bn)
- Rest of EU forecasted (2018-2023) market revenue (USD Bn)
- Rest of EU historical (2015-2017) market volume (Million units)
- Rest of EU forecasted (2018-2023) market volume (Million units)
Chapter 3: Europe major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal Europe (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib Europe (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP Europe (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal Europe (USD Bn, Million units)
.....
Get Complete TOC with Figures and Tables Here:https://www.researchreporthub.com/report/europe-conjugate-vaccine-market/11303/#toc
Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
About US
Research Report Hub
Sector 04, Plot 101, Sant Nagar,
Moshi PCNDTA, Pune, 412105
Maharashtra, India
Web:www.researchreporthub.com
Find us on: <||>rnhttps://www.facebook.com/reasearchreporthub/ <||>rnhttps://twitter.com/hub_report <||>rnhttps://www.linkedin.com/company/research-report-hub/
Contact Information:
Research Report Hub
Prakriti Mathur
Tel: +918448444687
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Research Report Hub
Prakriti Mathur
Tel: +918448444687
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results